Vir Biotechnology, Inc. Payments to Noncontrolling Interests
Vir Biotechnology, Inc. (VIR) reported Payments to Noncontrolling Interests of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToMinorityShareholders · last filed 2024-11-04
- Vir Biotechnology, Inc. payments to noncontrolling interests for the quarter ending 2024-09-30 was $0.00.
- Vir Biotechnology, Inc. payments to noncontrolling interests for the quarter ending 2023-12-31 was $0.00.
- Vir Biotechnology, Inc. payments to noncontrolling interests for the quarter ending 2023-09-30 was $0.00.
- Vir Biotechnology, Inc. payments to noncontrolling interests for the quarter ending 2022-12-31 was $0.00.
- Vir Biotechnology, Inc. payments to noncontrolling interests for fiscal 2023 was $100.00K.
- Vir Biotechnology, Inc. payments to noncontrolling interests for fiscal 2022 was $0.00.
- Vir Biotechnology, Inc. payments to noncontrolling interests for fiscal 2021 was $0.00.
| Period end | Payments to Noncontrolling Interests 3 month | Payments to Noncontrolling Interests 6 month | Payments to Noncontrolling Interests 9 month | Payments to Noncontrolling Interests 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 10-Q · filed 2024-11-04 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $0.00 derived: sum of 2 quarters · filed 2024-11-04 | $100.00K 10-K · filed 2024-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $100.00K 10-Q · filed 2024-11-04 | ||
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-01 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $0.00 derived: sum of 2 quarters · filed 2024-02-26 | $0.00 10-K · filed 2024-02-26 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |